These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6803202

  • 1. [Clinical trials with localized mitomycin instillation therapy for superficial urothelial bladder carcinoma].
    Flüchter SH, Bichler KH, Harzmann R, Erdmann D.
    Onkologie; 1982 Feb; 5(1):42-5. PubMed ID: 6803202
    [Abstract] [Full Text] [Related]

  • 2. [Local chemotherapy of bladder carcinoma with mitomycin (author's transl)].
    Flüchter SH, Harzmann R, Hlobil H, Erdmann W, Bichler KH.
    Urologe A; 1982 Jan; 21(1):24-8. PubMed ID: 6805121
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mitomycin C resorption following repeated intravesical instillations using different instillation times.
    van Helsdingen PJ, Rikken CH, Sleeboom HP, de Bruyn EA, Tjaden UR.
    Urol Int; 1988 Jan; 43(1):42-6. PubMed ID: 3131943
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH, Harzmann R, Erdmann D, Bichler KH.
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract] [Full Text] [Related]

  • 9. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH, Bouffioux C, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1988 Aug; 269():525-37. PubMed ID: 3134663
    [No Abstract] [Full Text] [Related]

  • 10. Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.
    Huland H, Otto U, Droese M, Klöppel G.
    J Urol; 1984 Jul; 132(1):27-9. PubMed ID: 6427483
    [Abstract] [Full Text] [Related]

  • 11. Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder.
    Serretta V, Piazza S, Pavone C, Piazza B, Pavone-Macaluso M.
    Urology; 1996 May; 47(5):647-51. PubMed ID: 8650860
    [Abstract] [Full Text] [Related]

  • 12. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP, DeBruyne FM.
    Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
    Pavlotsky A, Eidelman A, Barak F, Alon H, Horn Y.
    J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.
    Tsushima T, Matsumura Y, Ozaki Y, Yoshimoto J, Ohmori H.
    Cancer Chemother Pharmacol; 1987 May; 20 Suppl():S72-6. PubMed ID: 3117400
    [Abstract] [Full Text] [Related]

  • 15. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR, Griffin PP, Nocks BN, DeFuria MD, Daly JJ.
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [Abstract] [Full Text] [Related]

  • 16. Management of superficial bladder cancer in a community setting.
    Haas JA.
    Urology; 1985 Oct; 26(4 Suppl):51-4. PubMed ID: 3931328
    [Abstract] [Full Text] [Related]

  • 17. [Mitomycin C in the topical treatment of superficial neoplasms of the bladder].
    Milani C, Bassi PF, Meneghini A, Giunta A, Tejerizo JC, dal Bianco M, Zattoni F, Garbeglio A.
    Arch Esp Urol; 1989 Oct; 42(8):761-7. PubMed ID: 2515812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.